Literature DB >> 34321900

Blood Glucose and Renal Function Evaluation in Patients with Viral Hepatitis.

Wen-Tung Hsu1, Deng-Ho Yang1,2,3,4, Chun-Cheng Liao3,5, Jia-Wen Chen6, Wen-Hsiu Hsu3,7, Chia-Wen Kuo3,8, Hung-Chang Hsu9, Sheng-Huang Chang10, Li-Mien Chen2,3.   

Abstract

PURPOSE: To evaluate the blood glucose and renal function, determine the prevalence of hyperglycemia/diabetes mellitus (DM) and renal disease (nephropathy), and investigate the association between hyperglycemia/DM and renal disease in patients with viral hepatitis (VH). PATIENTS AND METHODS: A total of 491 subjects were included in the study. Patients with VH were further divided into the hepatitis B virus (HBV) infection, hepatitis C virus (HCV) infection, and HBV-HCV co-infection subgroups. Fasting blood glucose, glycated hemoglobin (HbA1c), glycated albumin (GA), glutamic oxaloacetic transaminase (GOT), creatinine (Cr), and cystatin C (Cys C) levels were measured. Urine microalbumin levels were also assessed. Formulas for estimated average glucose calculated using glycated albumin(eAG(GA)), estimated average glucose calculated using HbA1c (eAG(HbA1c)), and estimated glomerular filtration rate calculated using cystatin C (eGFRcys) were used to evaluate the average glucose and renal function.
RESULTS: The prevalence of hyperglycemia/DM and renal disease was significantly higher in the VH group, especially in the HCV subgroup. The prevalence of renal disease was significantly higher in patients with VH with eAG(GA) ≥200 mg/dL.
CONCLUSION: Our study used multiple parameters to evaluate blood glucose and renal function in patients with VH and found that hyperglycemia/DM and renal disease are closely associated with VH, especially in subjects with HCV infection. Patients with VH, especially those with HCV infection and hyperglycemia/DM, were particularly vulnerable to renal disease.
© 2021 Hsu et al.

Entities:  

Keywords:  diabetes mellitus; hyperglycemia; nephropathy; renal disease; viral hepatitis

Year:  2021        PMID: 34321900      PMCID: PMC8312512          DOI: 10.2147/DMSO.S303252

Source DB:  PubMed          Journal:  Diabetes Metab Syndr Obes        ISSN: 1178-7007            Impact factor:   3.168


  33 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  [A clinical analysis of liver disease patients with abnormal glucose metabolism].

Authors:  Xia Zhang; Wei Shen; Ding-ming Shen
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2006-04

3.  Assessing kidney function--measured and estimated glomerular filtration rate.

Authors:  Lesley A Stevens; Josef Coresh; Tom Greene; Andrew S Levey
Journal:  N Engl J Med       Date:  2006-06-08       Impact factor: 91.245

4.  Translating the A1C assay into estimated average glucose values: response to Nathan et al.

Authors:  Santiago Rodríguez-Segade; Javier Rodríguez; Juan Manuel Paz; Felix Camiña
Journal:  Diabetes Care       Date:  2009-01       Impact factor: 19.112

Review 5.  Measured GFR as a confirmatory test for estimated GFR.

Authors:  Lesley A Stevens; Andrew S Levey
Journal:  J Am Soc Nephrol       Date:  2009-10-15       Impact factor: 10.121

Review 6.  Chronic Kidney Disease.

Authors:  Adriano Luiz Ammirati
Journal:  Rev Assoc Med Bras (1992)       Date:  2020-01-13       Impact factor: 1.209

7.  HepCare Europe-A service innovation project. HepCheck: Characteristics of the patient population with active infection as defined by HCV RNA.

Authors:  Gordana Avramovic; Cristiana Oprea; Julian Surey; Alistair Story; Juan Macías; Walter Cullen; Maria Iglesias; Tina Mc Hugh; Des Crowley; Anna Marie Naughton; Aidan Horan; Irina Ianache; Stefan Lazar; Ionut Popa; Dee Menezes; John S Lambert
Journal:  Int J Infect Dis       Date:  2019-11-27       Impact factor: 3.623

Review 8.  2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020.

Authors: 
Journal:  Diabetes Care       Date:  2020-01       Impact factor: 19.112

9.  Translating the A1C assay into estimated average glucose values.

Authors:  David M Nathan; Judith Kuenen; Rikke Borg; Hui Zheng; David Schoenfeld; Robert J Heine
Journal:  Diabetes Care       Date:  2008-06-07       Impact factor: 19.112

10.  Diabetes mellitus and renal involvement in chronic viral liver disease.

Authors:  V F Iovanescu; C T Streba; M Ionescu; A F Constantinescu; C C Vere; I Rogoveanu; E Moța
Journal:  J Med Life       Date:  2015 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.